IL10 and cancer: In this regard, ICBs and various inhibitors such as indoleamine 2,3-dioxygenase (IDO), interleukin-10 (IL-10), and transforming growth factor-β (TGF-β) are widely used for combination cancer immunotherapy [58,59,60].